Back to News
DRUG RECALL ALERT - Recall of Chantix by Pfizer
September 22, 2021
Pfizer announced a voluntary consumer-level recall of all lots of Chantix (varenicline) tablets due to the presence of a nitrosamine, N-nitroso-varenicline, at or above the FDA interim acceptable daily intake limit.
Clinical Services will be conducting a drug recall mailing to potentially impacted members and providers. Below are mailing details.
Product
Manufacturer
Recall identification date
Affected NDCs
Look back period
Target population for clinical mailing
Messaging type
Data release
Fulfillment due date for NCQA compliance
Chantix (varenicline)
Pfizer
9/17/2021
0069-0468-56; 0069-0469-56; 0069-0469-03; 0069-0471-03
5/19/2021 – 9/17/2021
All
Mailing: Members; Direct Message/Fax: Providers
SS00005114
On or before: 10/07/21